Eloxx Pharmaceuticals, Inc.   Report issue

For profit Phase 2
Founded: Waltham MA United States (1999)

Organization Overview

First Clinical Trial
2016
NCT02807961
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Eloxx Pharmaceuticals, Inc.